Opaganib Protects against Radiation Toxicity: Implications for Homeland Security and Antitumor Radiotherapy.

Maines LW, Schrecengost RS, Zhuang Y, Keller SN, Smith RA, Green CL, Smith CD.

Open source

DOI
10.3390/ijms232113191
Published
2022-10-29
Container
Int J Mol Sci
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ijms232113191,
  title = {Opaganib Protects against Radiation Toxicity: Implications for Homeland Security and Antitumor Radiotherapy.},
  author = {Maines LW and  Schrecengost RS and  Zhuang Y and  Keller SN and  Smith RA and  Green CL and  Smith CD.},
  year = {2022},
  journal = {Int J Mol Sci},
  doi = {10.3390/ijms232113191},
  url = {https://doi.org/10.3390/ijms232113191}
}

RIS

TY  - JOUR
TI  - Opaganib Protects against Radiation Toxicity: Implications for Homeland Security and Antitumor Radiotherapy.
AU  - Maines LW
AU  -  Schrecengost RS
AU  -  Zhuang Y
AU  -  Keller SN
AU  -  Smith RA
AU  -  Green CL
AU  -  Smith CD.
PY  - 2022
JO  - Int J Mol Sci
DO  - 10.3390/ijms232113191
UR  - https://doi.org/10.3390/ijms232113191
ER  - 

APA

LW, M., RS, S., Y, Z., SN, K., RA, S., CL, G., & CD., S. (2022). Opaganib Protects against Radiation Toxicity: Implications for Homeland Security and Antitumor Radiotherapy.. Int J Mol Sci. https://doi.org/10.3390/ijms232113191

Source records